Literature DB >> 7076867

Incidence of hypercalcaemia and primary hyperparathyroidism in relation to the biochemical profile.

J S Harrop, J E Bailey, J S Woodhead.   

Abstract

Over a period of one year, 24500 patients underwent a biochemical profile investigation. Seven hundred and thirty-eight (3%) patients had a plasma calcium concentration of greater than 2.60 mmol/l, and hypercalcaemia was confirmed in 49.8% of those subjects from whom a second fasting sample was received. Primary hyperparathyroidism and malignant disease were the two commonest causes of hypercalcaemia, occurring with equal frequency. The overall incidence of primary hyperparathyroidism in our population was 1:680. Over 75% of the patients with primary hyperparathyroidism appeared to have asymptomatic disease. The merits of including a plasma calcium determination in a biochemical profile would seem to depend particularly on the natural history of asymptomatic primary hyperparathyroidism.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7076867      PMCID: PMC497668          DOI: 10.1136/jcp.35.4.395

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  26 in total

Review 1.  Current trends and problems in health screening.

Authors:  J M Wilson
Journal:  J Clin Pathol       Date:  1973-08       Impact factor: 3.411

2.  Treatment of primary hyperparathyroidism.

Authors:  D C Purnell; D A Scholz; L H Smith; G W Sizemore; M B Black; R S Goldsmith; C D Arnaud
Journal:  Am J Med       Date:  1974-06       Impact factor: 4.965

3.  Clinical findings in patients with hypercalcaemia. A preliminary investigation based on biochemical screening.

Authors:  P A Heedman; G Stenström
Journal:  Acta Med Scand       Date:  1973-03

4.  Serum calcium survey for hyperparathyroidism: results in 50,000 clinic patients.

Authors:  C E Boonstra; C E Jackson
Journal:  Am J Clin Pathol       Date:  1971-05       Impact factor: 2.493

5.  Serum multichannel autoanalyzers in the detection of hypercalcemia and hyperparathyroidism.

Authors:  E T Mays; S D Weakley
Journal:  Surg Gynecol Obstet       Date:  1971-10

6.  Immunoradiometric assay of parathyroid hormone.

Authors:  G M Addison; C N Hales; J S Woodhead; J L O'Riordan
Journal:  J Endocrinol       Date:  1971-03       Impact factor: 4.286

7.  Hypercalcaemia in an Australian hospital adult population.

Authors:  G McLellan; C W Baird; R Melick
Journal:  Med J Aust       Date:  1968-08-24       Impact factor: 7.738

8.  Primary hyperparathyroidism: changing clinical, surgical and pathologic aspects.

Authors:  R C Haff; W C Black; W F Ballinger
Journal:  Ann Surg       Date:  1970-01       Impact factor: 12.969

9.  Distribution of serum calcium and phosphorus values in unselected ambulatory patients.

Authors:  F R Keating; J D Jones; L R Elveback
Journal:  J Lab Clin Med       Date:  1969-09

10.  Interpretation of serum calcium in patients with abnormal serum proteins.

Authors:  R B Payne; A J Little; R B Williams; J R Milner
Journal:  Br Med J       Date:  1973-12-15
View more
  7 in total

1.  Hypercalcaemia in rheumatoid arthritis revisited.

Authors:  S H Ralston; W D Fraser; J Jankowski; I M Richards; R A Cowan; H A Capell; R D Sturrock
Journal:  Ann Rheum Dis       Date:  1990-01       Impact factor: 19.103

2.  The incidence and causes of hypercalcaemia.

Authors:  D M Dent; J L Miller; L Klaff; J Barron
Journal:  Postgrad Med J       Date:  1987-09       Impact factor: 2.401

3.  Bedside assessment of hypercalcaemia.

Authors:  F P Muldowney; R Freaney; M J McKenna
Journal:  Ir J Med Sci       Date:  1988-11       Impact factor: 1.568

4.  Primary hyperparathyroidism: the case for medical management.

Authors:  W Van'T Hoff; F W Ballardie; E J Bicknell
Journal:  Br Med J (Clin Res Ed)       Date:  1983-11-26

5.  Primary hyperparathyroidism in Austria: results of an 8-year prospective study.

Authors:  B Niederle; L Stamm; F Längle; E Schubert; W Woloszczuk; R Prager
Journal:  World J Surg       Date:  1992 Jul-Aug       Impact factor: 3.352

6.  The risk of cancer in primary care patients with hypercalcaemia: a cohort study using electronic records.

Authors:  F Hamilton; R Carroll; W Hamilton; C Salisbury
Journal:  Br J Cancer       Date:  2014-08-05       Impact factor: 7.640

Review 7.  A clinical perspective of parathyroid hormone related hypercalcaemia.

Authors:  Chau H Han; Christopher H Fry; Pankaj Sharma; Thang S Han
Journal:  Rev Endocr Metab Disord       Date:  2020-03       Impact factor: 6.514

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.